| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman of the Board | Executive Chairman of Board | Chairman and CEO +1 more
1 company
Stanley T Crooke last filed a Form 4 in January 2021, as Executive Chairman of the Board at IONS. Stanley T Crooke's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 2,021 shares of IONS. The IONS filings lean toward selling, a net 516,628 shares.
Stanley T Crooke has 23 Form 4 filings on record from January 2019 to January 2021, all as Executive Chairman of the Board at Ionis Pharmaceuticals (IONS), 2019–2021.
The 84 reported transactions were 43 open-market sales, 25 option exercises, 10 option or other derivative awards and 6 tax withholdings.
Counted by filing, the open-market trades come to no purchases and 17 sales worth about $30.3M.
The largest open-market sale was 77,000 shares of IONS at an average $60.77 on February 26, 2019, about $4.7M.
Shares as reported in the last Form 4 for each company; the most recent is from January 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2021 | IONS Ionis Pharmaceuticals Inc | Executive Chairman of the Board | Sell | 28,333 | $63.74 | $1,805,812.25 | -93.3% | |
| Jan 22, 2021 | IONS Ionis Pharmaceuticals Inc | Executive Chairman of the Board | Sell | 75,000 | $61.45 | $4,609,117.04 | -13.2% | |
| Dec 17, 2020 | IONS Ionis Pharmaceuticals Inc | Executive Chairman of the Board | Sell | 40,407 | $49.80 | $2,012,278.50 | -99.6% | |
| Dec 7, 2020 | IONS Ionis Pharmaceuticals Inc | Executive Chairman of the Board | Sell | 11,000 | $51.67 | $568,350.50 | -1.7% | |
| Nov 25, 2020 | IONS Ionis Pharmaceuticals Inc | Executive Chairman of the Board | Sale+OE | 12,990 | $50.05 | $650,149.50 | -86.5% | |
| Nov 24, 2020 | IONS Ionis Pharmaceuticals Inc | Executive Chairman of the Board | Sale+OE | 14,690 | $50.23 | $737,925.70 | -87.9% | |
| Sep 22, 2020 | IONS Ionis Pharmaceuticals Inc | Executive Chairman of the Board | Sell | 52,000 | $50.40 | $2,620,820.00 | -7.4% | |
| Jun 25, 2020 | IONS Ionis Pharmaceuticals Inc | Executive Chairman of the Board | Sell | 14,914 | $59.67 | $889,906.75 | -88.1% | |
| Jun 19, 2020 | IONS Ionis Pharmaceuticals Inc | Executive Chairman of the Board | Sell | 27,000 | $58.08 | $1,568,271.00 | -61.5% | |
| Mar 25, 2020 | IONS Ionis Pharmaceuticals Inc | Executive Chairman of the Board | Sell | 16,000 | $47.00 | $752,000.00 | -74.1% |